The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Association Between Myeloperoxidase Levels and Risk of Coronary Artery Disease
Abstract
CONTEXT: Myeloperoxidase (MPO), a leukocyte enzyme that promotes oxidation of lipoproteins in atheroma, has been proposed as a possible mediator of atherosclerosis. OBJECTIVE: To determine the association between MPO levels and prevalence of coronary artery disease (CAD). DESIGN, SETTING, AND PATIENTS: Case-control study conducted from July to September 2000 in a US tertiary care referral center, including 158 patients with established CAD (cases) and 175 patients without angiographically significant CAD (controls). MAIN OUTCOME MEASURES: Association of MPO levels per milligram of neutrophil protein (leukocyte-MPO) and MPO levels per milliliter of blood (blood-MPO) with CAD risk. RESULTS: Leukocyte- and blood-MPO levels were both significantly greater in patients with CAD than in controls (P<.001). In multivariable models adjusting for traditional cardiovascular risk factors, Framingham risk score, and white blood cell counts, MPO levels were significantly associated with presence of CAD, with an OR of 11.9 (95% CI, 5.5-25.5) for the highest vs lowest quartiles of leukocyte-MPO and an OR of 20.4 (95% CI, 8.9-47.2) for the highest vs lowest quartiles of blood-MPO. CONCLUSIONS: Elevated levels of leukocyte- and blood-MPO are associated with the presence of CAD. These findings support a potential role for MPO as an inflammatory marker in CAD and may have implications for atherosclerosis diagnosis and risk assessment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Markwell, M. A. K., Haas, S. M., Bieber, L. L., & Tolbert, N. E. (1978) · Analytical Biochemistry · doi:10.1016/0003-2697(78)90586-9 · Cited by 6,458
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Danesh, J., Collins, R., Appleby, P., & Peto, R. (1998) · JAMA · doi:10.1001/jama.279.18.1477 · Cited by 2,026
Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils
Eiserich, J. P., Hristova, M., Cross, C. E., Jones, A. D., Freeman, B. A., Halliwell, B., & van der Vliet, A. (1998) · Nature · doi:10.1038/34923 · Cited by 1,496
Daugherty, A., Dunn, J. L., Rateri, D. L., & Heinecke, J. W. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117342 · Cited by 1,269
Extensive Nitration of Protein Tyrosines in Human Atherosclerosis Detected by Immunohistochemistry
Beckmann, J. S., Ye, Y. Z., Anderson, P. G., Chen, J., Accavitti, M. A., Tarpey, M. M., & White, C. R. (1994) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1994.375.2.81 · Cited by 1,123
Febbraio, M., Podrez, E. A., Smith, J. D., Hajjar, D. P., Hazen, S. L., Hoff, H. F., Sharma, K., & Silverstein, R. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9259 · Cited by 1,044
Studies on the chlorinating activity of myeloperoxidase.
Harrison, J. E., & Schultz, J. (1976) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)33749-3 · Cited by 928
Hazen, S. L., & Heinecke, J. W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119379 · Cited by 842
Lipoprotein-Associated Phospholipase A2as an Independent Predictor of Coronary Heart Disease
Packard, C. J., O'Reilly, D. S. J., Caslake, M. J., McMahon, A. D., Ford, I., Cooney, J., Macphee, C. H., Suckling, K. E., Krishna, M., Wilkinson, F. E., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431603 · Cited by 823
Cited by
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Myeloperoxidase: friend and foe
Klebanoff, S. J. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.1204697 · Cited by 2,282
K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients
(2005) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.01.019 · Cited by 1,427
Pepe, M. S. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh101 · Cited by 1,276
Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations
Vasan, R. S. (2006) · Circulation · doi:10.1161/circulationaha.104.482570 · Cited by 1,212
Prognostic Value of Myeloperoxidase in Patients with Chest Pain
Brennan, M.-L., Penn, M. S., Van Lente, F., Nambi, V., Shishehbor, M. H., Aviles, R. J., Goormastic, M., Pepoy, M. L., McErlean, E. S., Topol, E. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035003 · Cited by 1,070
Reactive Oxygen Species in the Vasculature: Molecular and Cellular Mechanisms
Taniyama, Y., & Griendling, K. K. (2003) · Hypertension · doi:10.1161/01.hyp.0000100443.09293.4f · Cited by 1,066
Myeloperoxidase Serum Levels Predict Risk in Patients With Acute Coronary Syndromes
Baldus, S., Heeschen, C., Meinertz, T., Zeiher, A. M., Eiserich, J. P., Münzel, T., Simoons, M. L., & Hamm, C. W. (2003) · Circulation · doi:10.1161/01.cir.0000090690.67322.51 · Cited by 1,013
Insulin Resistance and Chronic Cardiovascular Inflammatory Syndrome
Fernández-Real, J. M., & Ricart, W. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0010 · Cited by 886
Oxidative stress and metabolic syndrome
Roberts, C. K., & Sindhu, K. K. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.02.026 · Cited by 866
Biological markers of oxidative stress: Applications to cardiovascular research and practice
Ho, E., Karimi Galougahi, K., Liu, C.-C., Bhindi, R., & Figtree, G. A. (2013) · Redox Biology · doi:10.1016/j.redox.2013.07.006 · Cited by 811
Myeloperoxidase and Cardiovascular Disease
Nicholls, S. J., & Hazen, S. L. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000163262.83456.6d · Cited by 795
The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models
Weber, C., Zernecke, A., & Libby, P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2415 · Cited by 776
Superparamagnetic Iron Oxide Nanoparticle Probes for Molecular Imaging
Thorek, D. L. J., Chen, A. K., Czupryna, J., & Tsourkas, A. (2006) · Annals of Biomedical Engineering · doi:10.1007/s10439-005-9002-7 · Cited by 772
Reactive oxygen species in cardiovascular disease
Sugamura, K., & Keaney (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.05.004 · Cited by 769
Oxidative stress in end-stage renal disease: an emerging threat to patient outcome
Locatelli, F., Canaud, B., Eckardt, K.-U., Stenvinkel, P., Wanner, C., & Zoccali, C. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg074 · Cited by 758
Zheng, L., Nukuna, B., Brennan, M.-L., Sun, M., Goormastic, M., Settle, M., Schmitt, D., Fu, X., Thomson, L., Fox, P. L., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421109 · Cited by 737
Protein carbamylation links inflammation, smoking, uremia and atherogenesis
Wang, Z., Nicholls, S. J., Rodriguez, E. R., Kummu, O., Hörkkö, S., Barnard, J., Reynolds, W. F., Topol, E. J., DiDonato, J. A., & Hazen, S. L. (2007) · Nature Medicine · doi:10.1038/nm1637 · Cited by 705
Inflammatory bio‐markers and cardiovascular risk prediction
Blake, G. J., & Ridker, P. M. (2002) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2002.01019.x · Cited by 702
Neutrophils as regulators of cardiovascular inflammation
Silvestre-Roig, C., Braster, Q., Ortega-Gomez, A., & Soehnlein, O. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0326-7 · Cited by 605
Mammalian Heme Peroxidases: From Molecular Mechanisms to Health Implications
Davies, M. J., Hawkins, C. L., Pattison, D. I., & Rees, M. D. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1927 · Cited by 560
Magnetic nanoparticle biosensors
Haun, J. B., Yoon, T., Lee, H., & Weissleder, R. (2010) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.84 · Cited by 550
Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation
Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541
Myeloperoxidase: Molecular Mechanisms of Action and Their Relevance to Human Health and Disease
van der Veen, B. S., de Winther, M. P. J., & Heeringa, P. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2538 · Cited by 518
Multiple Roles for Neutrophils in Atherosclerosis
Soehnlein, O. (2012) · Circulation Research · doi:10.1161/circresaha.111.257535 · Cited by 498
Oxidative stress and atherosclerosis
Singh, U., & Jialal, I. (2006) · Pathophysiology · doi:10.1016/j.pathophys.2006.05.002 · Cited by 490
Association of Nitrotyrosine Levels With Cardiovascular Disease and Modulation by Statin Therapy
Shishehbor, M. H., Aviles, R. J., Brennan, M.-L., Fu, X., Goormastic, M., Pearce, G. L., Gokce, N., Keaney, J. F., Penn, M. S., Sprecher, D. L., et al. (2003) · JAMA · doi:10.1001/jama.289.13.1675 · Cited by 464
“This was directly assessed in an interventional study comprised of 35 patients with a mean (SD) of 54 (10) years, 49% of whom were men.”
MethodPodrez, E. A., Poliakov, E., Shen, Z., Zhang, R., Deng, Y., Sun, M., Finton, P. J., Shan, L., Gugiu, B., Fox, P. L., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203318200 · Cited by 449
Self-citationMyeloperoxidase – A bridge linking inflammation and oxidative stress with cardiovascular disease
Ndrepepa, G. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.02.022 · Cited by 447
Meuwese, M. C., Stroes, E. S. G., Hazen, S. L., van Miert, J. N., Kuivenhoven, J. A., Schaub, R. G., Wareham, N. J., Luben, R., Kastelein, J. J. P., Khaw, K.-T., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.03.033 · Cited by 441
Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins
Lau, D., Mollnau, H., Eiserich, J. P., Freeman, B. A., Daiber, A., Gehling, U. M., Brümmer, J., Rudolph, V., Münzel, T., Heitzer, T., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405193102 · Cited by 434
Future Biomarkers for Detection of Ischemia and Risk Stratification in Acute Coronary Syndrome
Apple, F. S. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.046292 · Cited by 426
Established and Emerging Plasma Biomarkers in the Prediction of First Atherothrombotic Events
Ridker, P. M., Brown, N. J., Vaughan, D. E., Harrison, D. G., & Mehta, J. L. (2004) · Circulation · doi:10.1161/01.cir.0000133444.17867.56 · Cited by 422
Immune, inflammatory and cardiovascular consequences of sleep restriction and recovery
Faraut, B., Boudjeltia, K. Z., Vanhamme, L., & Kerkhofs, M. (2012) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2011.05.001 · Cited by 418
Zernecke, A., Bot, I., Djalali-Talab, Y., Shagdarsuren, E., Bidzhekov, K., Meiler, S., Krohn, R., Schober, A., Sperandio, M., Soehnlein, O., et al. (2008) · Circulation Research · doi:10.1161/circresaha.107.160697 · Cited by 417
Sugiyama, S., Kugiyama, K., Aikawa, M., Nakamura, S., Ogawa, H., & Libby, P. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000131784.50633.4f · Cited by 414
Myeloperoxidase as an Active Disease Biomarker: Recent Biochemical and Pathological Perspectives
Khan, A. A., Alsahli, M. A., & Rahmani, A. H. (2018) · Medical Sciences · doi:10.3390/medsci6020033 · Cited by 410
Döring, Y., Libby, P., & Soehnlein, O. (2020) · Circulation Research · doi:10.1161/circresaha.120.315931 · Cited by 410
Statins Promote Potent Systemic Antioxidant Effects Through Specific Inflammatory Pathways
Shishehbor, M. H., Brennan, M.-L., Aviles, R. J., Fu, X., Penn, M. S., Sprecher, D. L., & Hazen, S. L. (2003) · Circulation · doi:10.1161/01.cir.0000080895.05158.8b · Cited by 405
Sorrentino, S. A., Besler, C., Rohrer, L., Meyer, M., Heinrich, K., Bahlmann, F. H., Mueller, M., Horváth, T., Doerries, C., Heinemann, M., et al. (2010) · Circulation · doi:10.1161/circulationaha.108.836346 · Cited by 402
High-Density Lipoprotein Function, Dysfunction, and Reverse Cholesterol Transport
Fisher, E. A., Feig, J. E., Hewing, B., Hazen, S. L., & Smith, J. D. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.112.300133 · Cited by 393
Podrez, E. A., Poliakov, E., Shen, Z., Zhang, R., Deng, Y., Sun, M., Finton, P. J., Shan, L., Febbraio, M., Hajjar, D. P., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205924200 · Cited by 386
Self-citationThomas, S. R., Witting, P. K., & Drummond, G. R. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2027 · Cited by 383
“Thus, circulating MPO levels are elevated in CAD patients (571) and represent a strong, independent predictor of cardiovascular clinical events (27, 56) and endothelial dysfunction (510).”
Measuring Myeloperoxidase Activity in Biological Samples
Pulli, B., Ali, M., Forghani, R., Schob, S., Hsieh, K. L. C., Wojtkiewicz, G., Linnoila, J. J., & Chen, J. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067976 · Cited by 381
C-reactive protein and other inflammatory risk markers in acute coronary syndromes
Blake, G. J., & Ridker, P. M. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02953-4 · Cited by 367
Serum Myeloperoxidase Levels Independently Predict Endothelial Dysfunction in Humans
Vita, J. A., Brennan, M.-L., Gokce, N., Mann, S. A., Goormastic, M., Shishehbor, M. H., Penn, M. S., Keaney, J. F., & Hazen, S. L. (2004) · Circulation · doi:10.1161/01.cir.0000140262.20831.8f · Cited by 365
Inflammatory biomarkers in coronary artery disease
Zakynthinos, E., & Pappa, N. (2009) · Journal of Cardiology · doi:10.1016/j.jjcc.2008.12.007 · Cited by 359
Myeloperoxidase in kidney disease
Malle, E., Buch, T., & Grone, H.-J. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00336.x · Cited by 349
Tsimikas, S., Willerson, J. T., & Ridker, P. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.066 · Cited by 335
Baldus, S., Eiserich, J. P., Mani, A., Castro, L., Figueroa, M., Chumley, P., Ma, W., Tousson, A., White, C. R., Bullard, D. C., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12617 · Cited by 333
The Role of Myeloperoxidase in Biomolecule Modification, Chronic Inflammation, and Disease
Davies, M. J., & Hawkins, C. L. (2020) · Antioxidants & Redox Signaling · doi:10.1089/ars.2020.8030 · Cited by 332
O'Connor, C. M., Dunne, M. W., Pfeffer, M. A., Muhlestein, J. B., Yao, L., Gupta, S., Benner, R. J., Fisher, M. R., Cook, T. D., & for the Investigators in the WIZARD Study (2003) · JAMA · doi:10.1001/jama.290.11.1459 · Cited by 328
Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values
Dhama, K., Latheef, S. K., Dadar, M., Samad, H. A., Munjal, A., Khandia, R., Karthik, K., Tiwari, R., Yatoo, M. I., Bhatt, P., et al. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00091 · Cited by 321
eNOS Uncoupling in Cardiovascular Diseases - the Role of Oxidative Stress and Inflammation
Karbach, S., Wenzel, P., Waisman, A., Munzel, T., & Daiber, A. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660748 · Cited by 307
Biomarkers in acute myocardial infarction
Chan, D., & Ng, L. L. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-34 · Cited by 296
Role of Inflammation in Atherosclerosis
Spagnoli, L. G., Bonanno, E., Sangiorgi, G., & Mauriello, A. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.038661 · Cited by 293
Biochemistry of protein tyrosine nitration in cardiovascular pathology
PELUFFO, G., & RADI, R. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.04.024 · Cited by 291
Leukocytosis and Ischemic Vascular Disease Morbidity and Mortality: Is It Time to Intervene?
Coller, B. S. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000156877.94472.a5 · Cited by 286
Myeloperoxidase and its contributory role in inflammatory vascular disease
Lau, D., & Baldus, S. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.023 · Cited by 277
Shepherd, J., Hilderbrand, S. A., Waterman, P., Heinecke, J. W., Weissleder, R., & Libby, P. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.10.005 · Cited by 266
Novel biomarkers for cardiovascular risk prediction.
Wang, J., Tan, G.-J., Han, L.-N., Bai, Y., He, M., & Liu, H. (2017) · PubMed · doi:10.11909/j.issn.1671-5411.2017.02.008 · Cited by 256
Cardiac biomarkers and the case for point-of-care testing
McDonnell, B., Hearty, S., Leonard, P., & O'Kennedy, R. (2009) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2009.01.019 · Cited by 254
Smith, C. K., Vivekanandan‐Giri, A., Tang, C., Knight, J. S., Mathew, A., Padilla, R. L., Gillespie, B. W., Carmona‐Rivera, C., Liu, X., Subramanian, V., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38703 · Cited by 216
Thukkani, A. K., McHowat, J., Hsu, F.-F., Brennan, M.-L., Hazen, S. L., & Ford, D. A. (2003) · Circulation · doi:10.1161/01.cir.0000104564.01539.6a · Cited by 194
Self-citationAndrés, C. M. C., Pérez de la Lastra, J. M., Juan, C. A., Plou, F. J., & Pérez-Lebeña, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810735 · Cited by 166
Gałecki, P., Gałecka, E., Maes, M., Chamielec, M., Orzechowska, A., Bobińska, K., Lewiński, A., & Szemraj, J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.01.016 · Cited by 141
Pattison, D. I., Hawkins, C. L., & Davies, M. J. (2003) · Chemical Research in Toxicology · doi:10.1021/tx025670s · Cited by 139
Holistic nursing in practice: Mindfulness-based yoga as an intervention to manage stress and burnout
Hilcove, K., Marceau, C., Thekdi, P., Larkey, L., Brewer, M. A., & Jones, K. (2021) · Journal of Holistic Nursing · doi:10.1177/0898010120921587 · Cited by 92
Plasma myeloperoxidase is related to the severity of coronary artery disease
Düzgünçinar, Ö., Yavuz, B., Hazirolan, T., Deniz, A., Tokgözoglu, S. L., Akata, D., & Demirpençe, E. (2008) · Acta Cardiologica · doi:10.2143/ac.63.2.2029520 · Cited by 54
Therapeutic Targeting of Myeloperoxidase Attenuates NASH in Mice
Koop, A. C., Thiele, N. D., Steins, D., Michaëlsson, E., Wehmeyer, M., Scheja, L., Steglich, B., Huber, S., Schulze zur Wiesch, J., Lohse, A. W., et al. (2020) · Hepatology Communications · doi:10.1002/hep4.1566 · Cited by 48
Afshinnia, F., Zeng, L., Byun, J., Gadegbeku, C. A., Magnone, M. C., Whatling, C., Valastro, B., Kretzler, M., Pennathur, S., & Michigan Kidney Translational Core CPROBE Investigator Group (2017) · American Journal of Nephrology · doi:10.1159/000477766 · Cited by 43
Nitro-Oxidative Stress Biomarkers in Active and Inactive Men
Bjork, L., Jenkins, N., Witkowski, S., & Hagberg, J. (2012) · International Journal of Sports Medicine · doi:10.1055/s-0032-1301891 · Cited by 27
Tyrosine oxidation and nitration in transmembrane peptides is connected to lipid peroxidation
Bartesaghi, S., Herrera, D., Martinez, D. M., Petruk, A., Demicheli, V., Trujillo, M., Martí, M. A., Estrín, D. A., & Radi, R. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.04.006 · Cited by 18
Macer-Wright, J. L., Stanley, N. R., Portman, N., Tan, J. T., Bursill, C., Rayner, B. S., & Hawkins, C. L. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00044 · Cited by 18
New Clinical Markers Predictive of Cardiovascular Disease: The Role of Inflammatory Mediators
Rackley, C. E. (2004) · Cardiology in Review · doi:10.1097/01.crd.0000126083.86717.5b · Cited by 14
Metadata
- Authors
- Zhang, R.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2001-11-07
- Volume
- 286
- Issue
- 17
- Pages
- 2136
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2013204959
- Cited by
- 918
- References
- 47
- FWCI
- 11.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.